#GramNegativeBacteremia

JAMA Research Summary: Fast Antimicrobial Susceptibility Testing. Key findings: Rapid AST had a 48.8% desirable outcome, not superior to standard. No difference in mortality. Trial involved 850 patients in Greece, India, Israel, Spain.

Presented at #ESCMIDGlobal2026:

📊 Research Summary: In patients with #GramNegativeBacteremia, rapid #AntimicrobialSusceptibilityTesting did not improve 30-day outcomes compared with standard testing, although it supported faster antibiotic adjustments.

ja.ma/4cpmioY

JAMA study on Rapid AST vs Standard AST for gram-negative bacteremia (GNB). Population: 486 males, 364 females, median age 72. Intervention: @number randomized, @number analyzed. Findings: Alive without events, Rapid AST @number%, Standard AST @number%.

Presented at #ESCMIDGlobal2026: Among patients with #GramNegativeBacteremia, rapid #AntimicrobialSusceptibilityTesting did not improve 30-day clinical outcomes compared w/ standard testing, despite providing faster guidance for antibiotic escalation or deescalation.

ja.ma/4sILpcy

JAMA Research Summary: Fast Antimicrobial Susceptibility Testing. Key findings: Rapid AST had a 48.8% desirable outcome, not superior to standard. No difference in mortality. Trial involved 850 patients in Greece, India, Israel, Spain.

📊 Research Summary: In patients with #GramNegativeBacteremia, rapid #AntimicrobialSusceptibilityTesting did not improve 30-day outcomes compared with standard testing, although it supported faster antibiotic adjustments.

#ESCMIDGlobal2026

ja.ma/41KZyuS

JAMA study: Rapid antimicrobial susceptibility testing (AST) vs. standard AST for bloodstream infections. Conclusion: rapid AST wasn't superior. Population: 486 males, 364 females, median age 72. Intervention: text@1, text@2. Findings: alive at 30 days, similar rates.

Among patients with #GramNegativeBacteremia, rapid #AntimicrobialSusceptibilityTesting did not improve 30-day clinical outcomes compared with standard testing, despite providing faster guidance for antibiotic escalation or deescalation.

#ESCMIDGlobal2026

ja.ma/4sF52lG